Patients with a significant increase in hs-cTnI levels had more unfavorable clinical characteristics: they were older, had higher baseline blood pressure and LDL levels, had a history of MI and revascularization, and used fewer beta-blockers. Here, TNNI3 is linked to myocardial infarction.